An interventional study of Medication Reconciliation and Pharmaceutical Care in Elderly and Adverse Drug Event, sponsored by RWTH Aachen University. Completed at 1 site in Germany. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2017-01-11.
Sponsored by RWTH Aachen University · Not applicable, Interventional, and Health services research
The purpose of this study is to determine wether an extensive medication safety check has a greater impact on the incidence of adverse drug events than medication reconciliation or no intervention.
437 studies on the registry are indexed under Drug-Related Side Effects and Adverse Reactions; 76 are open to participants now.
This study's enrollment of 220 is above the median of 103 across 255 interventional studies indexed under Drug-Related Side Effects and Adverse Reactions.
Browse Drug-Related Side Effects and Adverse Reactions studies →RWTH Aachen University is the lead sponsor of 228 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patient randomized to the Control-Group will receive the traditional care by physician and nurse on the ward.
Patient randomized to the MedRec-Group will receive the traditional care by physician and nurse on the ward and additional pharmacist led medication reconciliation.
Other: Medication Reconciliation
Patient randomized to the AMTS-Group will receive the traditional care by physician and nurse on the ward and additional pharmaceutical care by a pharmacist.
Other: Pharmaceutical Care
Pharmacist take the best possible medication history (BPMH), comparison of the BPMH with the admission order (AMO), clarify and solve al discrepancies between the BPMH and the AMO.
Checking medication under safety considerations (medication at admission, during hospital stay, at discharge); recommendations for inappropriate medication (e.g. contraindications or interactions) or medication related problems. Pharmaceutical care includes Medication Reconciliation.
incidence of adverse drug events
Time frame: 1 year
Assessment of the clinical relevance of medication related problems as determined by the French Society of Clinical Pharmacy
Severity scale for medication related problems: minor, significative, major, critical, catastrophic
Time frame: 1 year
Assessment of the clinical relevance of discrepancies as determined by the French Society of Clinical Pharmacy
Severity scale for discrepancies: minor, significative, major, critical, catastrophic
Time frame: 1 year
number of medication related problems
Time frame: 1 year
number of discrepancies
Time frame: 1 year
duration of taking the best possible medication history
The duration is measured in minutes.
Time frame: 1 year
This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Drug-Related Side Effects and Adverse Reactions→
RWTH Aachen University